One of the major obstacles of chemotherapy is that, after repeated treatments, cellular resistance to the drug appears. The problem is that the tumor cells become resistant not only to the drugs which have been used during the treatment but also to other drugs which are structurally and functionally unrelated. This is termed 'multidrug resistance' (MDR). MDR is frequently associated with decreased drug accumulation resulting from enhanced drug efflux. This is correlated with the presence of a membrane protein, P-glycoprotein, which pumps a wide variety of drugs out of cells thus reducing their toxicity. The search for molecules able to reverse MDR is very important. We here report that mobile ionophores such as valinomycin, nonactin, nigericin, monensin, calcimycin, lasalocid inhibit the efflux of anthracycline by P-glycoprotein whereas, channel-forming ionophores such as gramicidin do not. Cyclosporin which is also a strong Ca 2+ chelating agent also inhibits the P-glycoprotein-mediated efflux of anthracycline.
This is termed 'muitidrug resistance' (MDR) [1, 2] .
Analysis of Multidnag Transporte.r in Living Cells. Inhibition of P-Glycoprotein-MediatedEffltvc of Anthracyclines by lonophores MDR is a now well-characterised phenomenon. The mechanisms of MDR are far from been elucidated and, in fact, modifications of several cellular functions have been observed. Thus, MDR is frequently associated with decreased drug accumulation resulting from enhanced drug efflux. This is correlated with the presence of a membrane protein, P-glycoprotein, which pumps a wide variety of drugs out of cells thus reducing their toxicity [3] [4] [5] [6] [7] . This drug efflux is ATP-dependent.
Genetic analysis suggests that P-gp is a member of a family of membrane associated transport proteins which are involved in multidrug resistance, malarial chloroquine resistance by Plasmodium falciparum, cystic fibrosis, peptide transport, heavy metal resistance and bacterial transport processes [8}. P-gp is also present in several normal tissues [9] . However, to date no naturally occurring substrates have been identified for P-gp.
The mechanism of the transport process is not known for any of the transporters of the ABC super family, including one reconstituted in artificial vesicles. The hydrolysis of .,TP apparently provides the energy for drug extrusion from the cell.
Perhaps the most puzzling question related to P-gp function is the unique ability of P-gp to recognise and transport a great number of apparently unrelated compounds. This transport can be inhibited by various compounds. It has been suggested that the minimum set of structural and functional features required for modulator binding to P-gp would be two planar aromatic domains and a nitrogen atom [101.
To analyse the function of the multidrug transporter in living cells, we have developed a method with which it is possible to follow the uptake of fluorescent drugs, such as anthracyclines, by cells, continuously, as incubation of the drug with the cells proceeds [11] [12] [13] [15] . Recent studies using carboxylic ionophores such as monensin and nigericin have indicated that these agents can modulate anthracycline toxicity apparently by causing an enhancement of anthracycline accumulation [16, 17] . It has also been noticed that the cytotoxic action of drugs as monensin [18] and nigericin ([19] may be assigned in the decrease cellular ATP levels. [12] On the other hand the membrane potential is the same for type of cells and has no effect on the THP-adriamycin "accumulation.
In the case of resistant cells we have observed that the addition of these ionophores lead to an increase of THP-adriamycin accumulation. For instance, when 106cells/ml are incubated with llaM THP-adriamycin, the overall concentration of drug bound to the nucleus at the steady state is (Cn)S=0.54tM and (Cn)R=0.251aM for sensitive and resistant cells respectively.The addition of ionophore to the resistant cells gives rise to an increase of (Cn)FI. If Under our experimental conditions, the amount of ionophores required to obtain x=0.5 is 0.31aM (nigericin), 0.41aM (lasalocid), 1.11aM (monensin), 1.21aM (caicimycin), 0.71aM (valinomycin), 0.31aM (nonactin). In the case of cyclosporin ,which is a now a well recognised MDR reverting agent, [20] .
Cyclosporin A is not considered as a mobile ionophore however it shared with this class of compounds a certain number of properties: its a strong metal chelating agent [21] , it can affect the physico-chemical properties of the plasma membrane it has been shown to bind to phospholipid vesicles ( [22] and depolarise cytoplasmic membrane potentials [23] . The 
